Literature DB >> 32108290

Heme Oxygenase-1 and Carbon Monoxide Regulate Growth and Progression in Glioblastoma Cells.

Carlo Castruccio Castracani1, Lucia Longhitano1, Alfio Distefano1, Michelino Di Rosa1, Valeria Pittalà2, Gabriella Lupo1, Massimo Caruso1, Daniela Corona1, Daniele Tibullo1, Giovanni Li Volti3.   

Abstract

In human glioma tumours, heme oxygenase-1 (HO-1) is overexpressed when compared with normal brain tissues and during oligodendroglioma progression. However, the molecular mechanisms mediated by HO-1 to promote glioblastoma remain unknown. We therefore aimed at investigating the effect of HO-1 expression and its selective enzymatic inhibition in two different cell lines (i.e. A172 and U87-MG). HO-1 was induced by hemin treatment (10 μM), and VP13/47 (100 μM) was used as a specific non-competitive inhibitor of HO-1 activity. Cell proliferation was measured by cell index measurement (xCelligence technology) and clonogenic assay, whereas cell migration was assessed by wound healing assay. Carbon monoxide-releasing molecules (CORMs) (i.e. CORM-3 and CORM-A1) were also used in a separate set of experiments to confirm the effect of HO-1 by-product in glioblastoma progression further. Our results were further validated using GSE4412 microarray dataset analysis and comparing biopsies overexpressing HO-1 with the rest of the cases. Our results showed that hemin was able to induce both HO-1 gene and protein expression in a cell-dependent manner being A172 more responsive to pharmacological upregulation of HO-1. Hemin, but not CORMs treatment, resulted in a significant increase of cell proliferation following 24 h of treatment as measured by increased cell index and colony formation capacity and such effect was abolished by VP13/47. Interestingly, both hemin and CORMs showed a significant effect on the wound healing assay also exhibiting cell specificity. Finally, our dataset analysis showed a positive correlation of HO-1 gene expression with ITGBI and ITGBII which are membrane receptors involved in cell adhesion, embryogenesis, tissue repair, immune response and metastatic diffusion of tumour cells. In conclusion, our data suggest that HO-1 and its by-product CO exhibit a cell-specific effect on various aspects of disease progression and are associated with a complex series of molecular mechanisms driving cell proliferation, survival and metastasis.

Entities:  

Keywords:  Biliverdin; Cancer; Carbon monoxide; Glioblastoma; Heme oxygenase; Nrf2; PUM2

Mesh:

Substances:

Year:  2020        PMID: 32108290     DOI: 10.1007/s12035-020-01869-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  43 in total

1.  Mutational landscape and clonal architecture in grade II and III gliomas.

Authors:  Hiromichi Suzuki; Kosuke Aoki; Kenichi Chiba; Yusuke Sato; Yusuke Shiozawa; Yuichi Shiraishi; Teppei Shimamura; Atsushi Niida; Kazuya Motomura; Fumiharu Ohka; Takashi Yamamoto; Kuniaki Tanahashi; Melissa Ranjit; Toshihiko Wakabayashi; Tetsuichi Yoshizato; Keisuke Kataoka; Kenichi Yoshida; Yasunobu Nagata; Aiko Sato-Otsubo; Hiroko Tanaka; Masashi Sanada; Yutaka Kondo; Hideo Nakamura; Masahiro Mizoguchi; Tatsuya Abe; Yoshihiro Muragaki; Reiko Watanabe; Ichiro Ito; Satoru Miyano; Atsushi Natsume; Seishi Ogawa
Journal:  Nat Genet       Date:  2015-04-13       Impact factor: 38.330

2.  Cutting Edge: ERK1 Mediates the Autocrine Positive Feedback Loop of TGF-β and Furin in Glioma-Initiating Cells.

Authors:  Elisa Ventura; Michael Weller; Isabel Burghardt
Journal:  J Immunol       Date:  2017-05-08       Impact factor: 5.422

3.  Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.

Authors:  Daphne A Haas-Kogan; Michael D Prados; Tarik Tihan; David A Eberhard; Nannette Jelluma; Nils D Arvold; Rachel Baumber; Kathleen R Lamborn; Ami Kapadia; Mary Malec; Mitchel S Berger; David Stokoe
Journal:  J Natl Cancer Inst       Date:  2005-06-15       Impact factor: 13.506

4.  Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.

Authors:  James R Perry; Normand Laperriere; Christopher J O'Callaghan; Alba A Brandes; Johan Menten; Claire Phillips; Michael Fay; Ryo Nishikawa; J Gregory Cairncross; Wilson Roa; David Osoba; John P Rossiter; Arjun Sahgal; Hal Hirte; Florence Laigle-Donadey; Enrico Franceschi; Olivier Chinot; Vassilis Golfinopoulos; Laura Fariselli; Antje Wick; Loic Feuvret; Michael Back; Michael Tills; Chad Winch; Brigitta G Baumert; Wolfgang Wick; Keyue Ding; Warren P Mason
Journal:  N Engl J Med       Date:  2017-03-16       Impact factor: 91.245

5.  Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress.

Authors:  Zulfiqar Ahmad; Mohammad Salim; Mahin D Maines
Journal:  J Biol Chem       Date:  2001-12-31       Impact factor: 5.157

Review 6.  Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets?

Authors:  Florence Lefranc; Emilie Le Rhun; Robert Kiss; Michael Weller
Journal:  Cancer Treat Rev       Date:  2018-06-26       Impact factor: 12.111

7.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

8.  Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

Authors:  Marc Sanson; Yannick Marie; Sophie Paris; Ahmed Idbaih; Julien Laffaire; François Ducray; Soufiane El Hallani; Blandine Boisselier; Karima Mokhtari; Khe Hoang-Xuan; Jean-Yves Delattre
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

9.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

10.  IDH1 and IDH2 mutations in gliomas.

Authors:  Hai Yan; D Williams Parsons; Genglin Jin; Roger McLendon; B Ahmed Rasheed; Weishi Yuan; Ivan Kos; Ines Batinic-Haberle; Siân Jones; Gregory J Riggins; Henry Friedman; Allan Friedman; David Reardon; James Herndon; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Darell D Bigner
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 176.079

View more
  7 in total

Review 1.  Adaptive Changes Allow Targeting of Ferroptosis for Glioma Treatment.

Authors:  Renxuan Huang; Rui Dong; Nan Wang; Yichun He; Peining Zhu; Chong Wang; Beiwu Lan; Yufei Gao; Liankun Sun
Journal:  Cell Mol Neurobiol       Date:  2021-04-24       Impact factor: 4.231

2.  Head-to-Head Comparison of Selected Extra- and Intracellular CO-Releasing Molecules on Their CO-Releasing and Anti-Inflammatory Properties.

Authors:  Yingchun Li; Lars Hemmersbach; Bernhard Krause; Nikolay Sitnikov; Anna Schlundt Née Göderz; Diego O Pastene Maldonado; Hans-Günther Schmalz; Benito Yard
Journal:  Chembiochem       Date:  2021-10-26       Impact factor: 3.461

Review 3.  The Diverse Roles of Heme Oxygenase-1 in Tumor Progression.

Authors:  Kim Ngan Luu Hoang; Joanne E Anstee; James N Arnold
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

4.  Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity.

Authors:  Giuseppe Romeo; Valeria Ciaffaglione; Emanuele Amata; Maria Dichiara; Loredana Calabrese; Luca Vanella; Valeria Sorrenti; Salvo Grosso; Agata Grazia D'Amico; Velia D'Agata; Sebastiano Intagliata; Loredana Salerno
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

5.  Expression Dynamics of Heme Oxygenase-1 in Tumor Cells and the Host Contributes to the Progression of Tumors.

Authors:  Jun Fang; Rayhanul Islam; Shanghui Gao; Cheng Zhang; Ryotaro Kunisaki; Shogo Sakaguchi; Naoya Honda; Jian-Rong Zhou; Kazumi Yokomizo
Journal:  J Pers Med       Date:  2021-12-09

6.  Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent In Vitro Antiproliferative Activity.

Authors:  Antonino N Fallica; Valeria Sorrenti; Agata G D'Amico; Loredana Salerno; Giuseppe Romeo; Sebastiano Intagliata; Valeria Consoli; Giuseppe Floresta; Antonio Rescifina; Velia D'Agata; Luca Vanella; Valeria Pittalà
Journal:  J Med Chem       Date:  2021-09-02       Impact factor: 7.446

Review 7.  Heme oxygenase 1: a novel oncogene in multiple gynecological cancers.

Authors:  Jia-Jing Lu; Ayitila Abudukeyoumu; Xing Zhang; Li-Bing Liu; Ming-Qing Li; Feng Xie
Journal:  Int J Biol Sci       Date:  2021-06-01       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.